Romidepsin Enhances the Efficacy of Cytarabine in Vivo, Revealing Histone Deacetylase Inhibition as a Promising Therapeutic Strategy for KMT2A-rearranged Infant Acute Lymphoblastic Leukemia

Haematologica - Italy
doi 10.3324/haematol.2018.192906
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

CD19-Targeted Nanodelivery of Doxorubicin Enhances Therapeutic Efficacy in B-Cell Acute Lymphoblastic Leukemia

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2015English

Rationale for Targeting BCL6 in MLL-rearranged Acute Lymphoblastic Leukemia

Genes and Development
GeneticsDevelopmental Biology
2019English

Characterisation of the Novel Apoptotic and Therapeutic Activities of the Histone Deacetylase Inhibitor Romidepsin

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Integrin Alpha4 as a Therapeutic Target of Acute Lymphoblastic Leukemia

Journal of Blood Disorders & Transfusion
2014English

Hypermethylation of Specific microRNA Genes in MLL-rearranged Infant Acute Lymphoblastic Leukemia: Major Matters at a Micro Scale

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Bone Marrow Necrosis Revealing Acute Lymphoblastic Leukemia

European Paediatric Haematology and Oncology
1985English

Treatment Outcome in Infant Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2000English

Inhibition of Notch Signaling Enhances Chemosensitivity in B Cell Precursor Acute Lymphoblastic Leukemia.

Cancer Research
Cancer ResearchOncology
2018English

The Role of Constitutive Activation of FMS-related Tyrosine Kinase-3 and NRas/KRas Mutational Status in Infants With KMT2A-rearranged Acute Lymphoblastic Leukemia

Haematologica
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy